Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation (Tables)

v3.20.2
Stock-Based Compensation (Tables)
 9 Months Ended
Sep. 30, 2020
Stock-Based Compensation [Abstract]  
Summary Of Stock Compensation Expense



 

 

 

 

 

 

 

 



For the Three Months Ended

September 30,

For the Nine Months Ended

September 30,



2020

2019

2020

2019

Statement of operations line item:

 

 

 

 

 

 

 

 

General and administrative

$

 54,501 

$

 84,378 

$

 193,272 

$

 320,776 

Research and development

 

 2,340 

 

 6,317 

 

 8,940 

 

 58,572 



 

 

 

 

 

 

 

 

Total

$

 56,841 

$

 90,695 

$

 202,212 

$

 379,348 



Summary Of Share-Based Transactions



 

 

 

 

 

 



 

 

 

 



Number of Options

 

Weighted Average Exercise Price

Weighted Average Remaining Contractual Term

 

Aggregate Intrinsic Value

Outstanding, January 1, 2020

 204,574 

$

 35.60 

7.3 years

$

 -

Granted

 -

$

 -

 

 

 

Exercised

 -

$

 -

 

 

 

Expired

 (3,162)

$

 155.69 

 

 

 

Cancelled

 (55,354)

$

 59.54 

 

 

 



 

 

 

 

 

 

Outstanding, September 30, 2020

 146,058 

$

 23.92 

7.4 years

$

 -

Exercisable, September 30, 2020

 102,939 

$

 27.98 

7.1 years

$

 -



Summary Of Unvested Shares



 

 

 



 

 

 



2020



Number of  Options

Weighted Average Fair Value at Grant Date

Unvested at January 1, 2020

 81,311 

$

 7.90 

Granted

 -

$

 -

Vested

 (37,398)

$

 6.20 

Cancelled

 (794)

$

 9.12 



 

 

 

Unvested at September 30,  2020

 43,119 

$

 9.39